Skip to content
Lower risk Medical device recall · FDA · Published January 8, 2021

DeP: Universal Femoral Sleeves Recall - Taper Dimensions May Be Out of Specification

DePuy recalls Universal Femoral Sleeves used in revision knee surgeries due to potential taper dimension issues from manufacturing. Affected lots include J85Y90, J86T23, J86T20, J8790J, J85Y92. Contact for details.

🇺🇸 FDA recall #Z-1103-2021Medical deviceDePuy ›
Take action

Contact the company

Recalling firmDePuy Orthopaedics, Inc.700 Orthopaedic Dr · Warsaw, IN 46582-3994
✎ GovInfoNow plain-language explainer

What happened, in plain English

DePuy recalls certain Universal Femoral Sleeves used in revision knee surgeries because their taper dimensions might be out of specification due to a manufacturing issue. This could affect the safety of the surgical procedure if the sleeves don't fit properly. Read more at govinfonow.com/recall/63439-dep-universal-femoral-sleeves-recall-taper-dimensions-may-be-out.

Source Summary by GovInfoNow · govinfonow.com/recall/63439-dep-universal-femoral-sleeves-recall-taper-dimensions-may-be-out · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1103-2021

Cite this page

“DeP: Universal Femoral Sleeves Recall - Taper Dimensions May Be Out of Specification.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63439-dep-universal-femoral-sleeves-recall-taper-dimensions-may-be-out. Based on FDA recall #Z-1103-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1103-2021%22&limit=1).

Why it’s dangerous

The taper dimensions of the sleeves may be out of specification due to a manufacturing issue. This could lead to improper fitting during revision knee surgeries, potentially affecting surgical outcomes.

Who’s affected

Surgical teams using these sleeves in revision knee surgeries are most at risk. Patients receiving these sleeves during the specified production lots are affected.

How to tell if you have this one

Check the lot numbers: J85Y90, J86T23, J86T20, J8790J, or J85Y92. These sleeves are used with S-ROM Noiles, LPS, SIGMA, and LCS knee products in revision surgeries.

  • Brand
    DePuy
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Look for lot numbers J85Y90, J86T23, J86T20, J8790J, or J85Y92 on the sleeves.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 13 states.

Alaska: named in the noticeAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: nationwideILWisconsin: nationwideWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: named in the noticeMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of AK, CA, FL, IN, MI, MN, MS, NC, NY, OH, PA, TX, VA and the countries of Canada, China, Germany, Puerto Rico, Switzerland.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alaska, California, Florida, Indiana, Michigan, Minnesota, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Puerto Rico, Texas, Virginia.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Jan 8, 202112. FDA classified it Class II: Feb 9, 202123. Published in FDA’s Enforcement Report: Feb 17, 202134. FDA terminated the recall: Jan 17, 2024420212024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1103-2021 (January 8, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1103-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA